Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2003

01-11-2003 | Brief Report

Reference Values for the SERION classic ELISA for Detecting Legionella pneumophila Antibodies

Authors: H. C. Boshuizen, J. W. Den Boer, H. de Melker, J. F. P. Schellekens, M. F. Peeters, J. A. van Vliet, M. A. E. Conyn-van Spaendonck

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2003

Login to get access

Excerpt

The first serological test to identify antibodies against Legionella pneumophila was the indirect immunofluorescence antibody test (IFAT) developed in 1977 at the Centers for Disease Control, Atlanta, Ga., USA [1]. Several other tests have since been developed, among them rapid microagglutination tests (RMAT) [2] and numerous (mostly experimental) enzyme-linked immunosorbent assays (ELISA). …
Literature
1.
McDade JE, Shepard CC, Fraser DW, et al (1977) Legionnaires’ disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 297:1197–1203PubMed
2.
Harrison TG, Taylor AG (1982) A rapid microagglutination test for the diagnosis of Legionella pneumophila (serogroup 1) infection. J Clin Pathol 35:1028–1031PubMed
3.
Etienne J, Vandenesch F, Lina G, Jarraud S (1999) Evaluierung des SERION ELISA classic Legionella pneumophila 1–7 (IgG, IgM). In: SERION Legionella pneumophila 1–7 studies ELISA classic. Clindia Benelux b.v. Leusden, pp 1–11
4.
Heudorf U, Hentschel W, Hoffmann M, et al (2001) Legionellen im hauseigenen Warmwasser–Auswirkungen auf die Gesundheit der Bewohner. Gesundheitswesen 63:326–334PubMed
5.
De Melker HE, Conyn-van Spaendonck MAE (1998) Immunosurveillance and the evaluation of national immunisation programmes: a population-based approach. Epidemiol Infect 121:637–643CrossRefPubMed
6.
Boshuizen HC, Neppelenbroek SE, van Vliet H, et al (2001) Subclinical Legionella infection in workers near the source of a large outbreak of legionnaires disease. J Infect Dis 184:515–518CrossRefPubMed
7.
CLINDIA Benelux (1999) Scientific information on SERION ELISA classic (serogroups 1 to 7) IgG and IgM. CLINDIA Benelux B.V., Leusden, The Netherlands
8.
Harrison TG, Taylor AG (1988) The diagnosis of legionnaires’ disease by estimation of antibody levels. In: Harrison TG, Taylor AG (eds) A laboratory manual for Legionella. John Wiley, Chichester pp 130–136
9.
Wright EM, Royston P (1997) Simplified estimation of age-specific reference intervals for skewed data. Stat Med 16:2785–2803CrossRefPubMed
10.
Hoge CW, Breiman RF (1991) Advances in the epidemiology and control of Legionella infections. Epidemiol Rev 13:329–340PubMed
11.
Den Boer JW, Yzerman EP, Schellekens J, et al (2002) A large outbreak of legionnaires’ disease at a flower show, the Netherlands, 1999. Emerg Infect Dis 8:37–43PubMed
Metadata
Title
Reference Values for the SERION classic ELISA for Detecting Legionella pneumophila Antibodies
Authors
H. C. Boshuizen
J. W. Den Boer
H. de Melker
J. F. P. Schellekens
M. F. Peeters
J. A. van Vliet
M. A. E. Conyn-van Spaendonck
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-1033-0

Other articles of this Issue 11/2003

European Journal of Clinical Microbiology & Infectious Diseases 11/2003 Go to the issue

Brief Report

Micrococcus Infection in Patients Receiving Epoprostenol by Continuous Infusion

Article

External Quality Control of Direct Antigen Tests to Detect Group A Streptococcal Antigen

Letter to the Editor

Comments on the Failure to Detect Chlamydia pneumoniae in Atherosclerosis

Article

Voriconazole Salvage Treatment of Invasive Candidiasis

Concise Article

Nosocomial Cluster of Candida guillermondii Fungemia in Surgical Patients

Article

Declining Incidence of AIDS and Increasing Prevalence of AIDS Presenters Among AIDS Patients in Italy
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits